603207 小方制药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)4.99317.83322.63042.76558.251
总资产报酬率 ROA (%)4.47915.70719.41034.63241.252
投入资产回报率 ROIC (%)4.94017.73722.57142.57356.712

边际利润分析
销售毛利率 (%)60.92565.00065.61465.46359.037
营业利润率 (%)45.01745.97950.53250.05245.165
息税前利润/营业总收入 (%)44.79745.33849.20549.95044.937
净利润/营业总收入 (%)38.44139.50143.25343.15338.342

收益指标分析
经营活动净收益/利润总额(%)100.301100.42399.42597.43396.210
价值变动净收益/利润总额(%)0.0000.0000.0070.9501.442
营业外收支净额/利润总额(%)-0.190-0.121-0.1290.417-0.142

偿债能力分析
流动比率 (X)7.9705.8766.1373.4203.644
速动比率 (X)7.4225.4035.8683.0433.009
资产负债率 (%)8.79011.83711.99418.62019.628
带息债务/全部投入资本 (%)1.2640.8250.2540.1640.490
股东权益/带息债务 (%)7,809.34512,012.42039,219.49360,752.81620,243.307
股东权益/负债合计 (%)1,037.669744.836733.730437.052409.475
利息保障倍数 (X)-332.092-77.390-39.003-160.364-273.748

营运能力分析
应收账款周转天数 (天)77.48571.80365.70763.80554.195
存货周转天数 (天)102.674111.992104.905118.297106.348